Everolimus (Afinitor®, Zortress®) is a prescription medication licensed for the treatment of certain types of cancers and tumors, and also to help prevent organ rejection after a kidney or liver transplant. Although this can be an effective medicine, it can cause problems for some people.
For example, some people using everolimus can experience delayed wound healing. This can increase the risk for wound problems, including potentially serious infections. Make sure to contact your healthcare provider if you have wounds or sores that do not heal, or if you had a kidney transplant and your surgical cut (incision site):
Does not seem to be healing
Becomes red, swollen, or painful
Fills with pus, fluid, or blood.
(For more information, click Everolimus. This full-length article takes an in-depth look at this prescription medicine, including how it works, potential side effects, and other safety precautions to be aware of before starting treatment.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Afinitor [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2012 August.
Zortress [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation;2013 February.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 27, 2011.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed July 28, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click